The Food & Drug Administration announced last week that the Ozempic and Wegovy shortage for Novo Nordisk‘s (NYSE:NVO) was ...

The 35-year-old software developer, based in China's western metropolis of Chengdu, is about to start his third month on Ozempic, the brand name that pharmaceutical giant Novo Nordisk gives to ...

With Novo Nordisk’s blockbuster drugs Wegovy and Ozempic back in stock, copycat versions of semaglutide are no longer allowed ...

Shortages of Ozempic and Wegovy that have been in place for more than two years have been resolved, as supplies of the ...

Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in shortage, the US Food and Drug Administration ...

Semaglutide — the key ingredient in Ozempic and Wegovy — had been in shortage since 2022. Now that supply has stabilized, state-licensed compounding pharmacies and physicians must stop selling ...

We recently published a list of Renaissance Technologies Portfolio: Top 10 Stock Picks. In this article, we are going to take ...

The medical director of the NHS has warned of the side effects of weight loss drugs after figures revealed the number of ...

These two stocks are poised to crush the market thanks to their outsize growth prospects and dirt cheap valuations.

Besides Mankind, Natco Pharma, Dr Reddy’s, Sun Pharma and others are already gearing up for launches of weight-loss drugs ...

Makers of copycat weight-loss drugs and digital health companies that sell them are bracing for upheaval now that the Food ...